SC 13G/AAMENDMENTAPRECIK 0001781983

Aprea Therapeutics, Inc.

Name: SEC EDGAR filing 0000935836-26-000399
Creator: Aprea Therapeutics, Inc.
License: https://www.usa.gov/government-works

5%+ passive stake (SC 13G/A) filed August 13, 2026.

Short-form disclosure of beneficial ownership above 5% by passive investors with no control intent.

Filing facts

Accession number: 0000935836-26-000399
Filer: Aprea Therapeutics, Inc.
Ticker: APRE
CIK: 0001781983
Form type: SC 13G/A
Form description: 5%+ passive stake
Filed at: August 13, 2026
Industry: SIC 2834Pharmaceutical Preparations
Last verified: August 26, 2026SecFilingDex pulls from EDGAR with daily cadence

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/1781983/000093583626000399/0000935836-26-000399-index.htm ↗

Filer's full EDGAR submission history

EDGAR · Aprea Therapeutics, Inc. (0001781983) ↗

Machine-readable JSON twin (LLM-citation friendly)

/api/filing/0000935836-26-000399.json

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.